304 related articles for article (PubMed ID: 34534142)
1. Current emerging MRI tools for radionecrosis and pseudoprogression diagnosis.
Nichelli L; Casagranda S
Curr Opin Oncol; 2021 Nov; 33(6):597-607. PubMed ID: 34534142
[TBL] [Abstract][Full Text] [Related]
2. Treatment-related changes in glioblastoma: a review on the controversies in response assessment criteria and the concepts of true progression, pseudoprogression, pseudoresponse and radionecrosis.
Delgado-López PD; Riñones-Mena E; Corrales-García EM
Clin Transl Oncol; 2018 Aug; 20(8):939-953. PubMed ID: 29218626
[TBL] [Abstract][Full Text] [Related]
3. Imaging Glioblastoma Posttreatment: Progression, Pseudoprogression, Pseudoresponse, Radiation Necrosis.
Strauss SB; Meng A; Ebani EJ; Chiang GC
Radiol Clin North Am; 2019 Nov; 57(6):1199-1216. PubMed ID: 31582045
[TBL] [Abstract][Full Text] [Related]
4. What effective technique to differentiate radiation brain necrosis from a tumor progression in patients treated with radiation: A monocentric retrospective study combining the MRI TRAMs technique and the (
Lakehayli Z; Phlips P; Margoum A; Saoudi A; Hmaid L; Nejjar I; Oueslati H; Bourgois N; Dao S; Belkhir F
Cancer Radiother; 2023 Jun; 27(4):273-280. PubMed ID: 37080856
[TBL] [Abstract][Full Text] [Related]
5. Pseudoprogression, radionecrosis, inflammation or true tumor progression? challenges associated with glioblastoma response assessment in an evolving therapeutic landscape.
Ellingson BM; Chung C; Pope WB; Boxerman JL; Kaufmann TJ
J Neurooncol; 2017 Sep; 134(3):495-504. PubMed ID: 28382534
[TBL] [Abstract][Full Text] [Related]
6. Umbrella review and network meta-analysis of diagnostic imaging test accuracy studies in Differentiating between brain tumor progression versus pseudoprogression and radionecrosis.
Dagher R; Gad M; da Silva de Santana P; Sadeghi MA; Yewedalsew SF; Gujar SK; Yedavalli V; Köhler CA; Khan M; Tavora DGF; Kamson DO; Sair HI; Luna LP
J Neurooncol; 2024 Jan; 166(1):1-15. PubMed ID: 38212574
[TBL] [Abstract][Full Text] [Related]
7. Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2.
Muto M; Frauenfelder G; Senese R; Zeccolini F; Schena E; Giurazza F; Jäger HR
Radiol Med; 2018 Jul; 123(7):545-552. PubMed ID: 29508242
[TBL] [Abstract][Full Text] [Related]
8. Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas.
Ma B; Blakeley JO; Hong X; Zhang H; Jiang S; Blair L; Zhang Y; Heo HY; Zhang M; van Zijl PC; Zhou J
J Magn Reson Imaging; 2016 Aug; 44(2):456-62. PubMed ID: 26788865
[TBL] [Abstract][Full Text] [Related]
9. Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology.
Detsky JS; Keith J; Conklin J; Symons S; Myrehaug S; Sahgal A; Heyn CC; Soliman H
J Neurooncol; 2017 Sep; 134(2):433-441. PubMed ID: 28674974
[TBL] [Abstract][Full Text] [Related]
10. Shape Features of the Lesion Habitat to Differentiate Brain Tumor Progression from Pseudoprogression on Routine Multiparametric MRI: A Multisite Study.
Ismail M; Hill V; Statsevych V; Huang R; Prasanna P; Correa R; Singh G; Bera K; Beig N; Thawani R; Madabhushi A; Aahluwalia M; Tiwari P
AJNR Am J Neuroradiol; 2018 Dec; 39(12):2187-2193. PubMed ID: 30385468
[TBL] [Abstract][Full Text] [Related]
11. Combined use of susceptibility weighted magnetic resonance imaging sequences and dynamic susceptibility contrast perfusion weighted imaging to improve the accuracy of the differential diagnosis of recurrence and radionecrosis in high-grade glioma patients.
Kim TH; Yun TJ; Park CK; Kim TM; Kim JH; Sohn CH; Won JK; Park SH; Kim IH; Choi SH
Oncotarget; 2017 Mar; 8(12):20340-20353. PubMed ID: 27823971
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery.
Cicone F; Minniti G; Romano A; Papa A; Scaringi C; Tavanti F; Bozzao A; Maurizi Enrici R; Scopinaro F
Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):103-11. PubMed ID: 25182751
[TBL] [Abstract][Full Text] [Related]
13. Interval Change in Diffusion and Perfusion MRI Parameters for the Assessment of Pseudoprogression in Cerebral Metastases Treated With Stereotactic Radiation.
Knitter JR; Erly WK; Stea BD; Lemole GM; Germano IM; Doshi AH; Nael K
AJR Am J Roentgenol; 2018 Jul; 211(1):168-175. PubMed ID: 29708785
[TBL] [Abstract][Full Text] [Related]
14. Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor: a systematic review.
Furuse M; Nonoguchi N; Yamada K; Shiga T; Combes JD; Ikeda N; Kawabata S; Kuroiwa T; Miyatake SI
Radiat Oncol; 2019 Feb; 14(1):28. PubMed ID: 30728041
[TBL] [Abstract][Full Text] [Related]
15. Computer-Extracted Texture Features to Distinguish Cerebral Radionecrosis from Recurrent Brain Tumors on Multiparametric MRI: A Feasibility Study.
Tiwari P; Prasanna P; Wolansky L; Pinho M; Cohen M; Nayate AP; Gupta A; Singh G; Hatanpaa KJ; Sloan A; Rogers L; Madabhushi A
AJNR Am J Neuroradiol; 2016 Dec; 37(12):2231-2236. PubMed ID: 27633806
[TBL] [Abstract][Full Text] [Related]
16. Differentiation between Radiation Necrosis and Tumor Progression Using Chemical Exchange Saturation Transfer.
Mehrabian H; Desmond KL; Soliman H; Sahgal A; Stanisz GJ
Clin Cancer Res; 2017 Jul; 23(14):3667-3675. PubMed ID: 28096269
[No Abstract] [Full Text] [Related]
17. Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology.
Brandes AA; Tosoni A; Spagnolli F; Frezza G; Leonardi M; Calbucci F; Franceschi E
Neuro Oncol; 2008 Jun; 10(3):361-7. PubMed ID: 18401015
[TBL] [Abstract][Full Text] [Related]
18. Incidence of intracranial radiation necrosis following postoperative radiation therapy for sinonasal malignancies.
Ahmad S; Le CH; Chiu AG; Chang EH
Laryngoscope; 2016 Nov; 126(11):2445-2450. PubMed ID: 27296477
[TBL] [Abstract][Full Text] [Related]
19. Advanced multimodal imaging in differentiating glioma recurrence from post-radiotherapy changes.
Li C; Gan Y; Chen H; Chen Y; Deng Y; Zhan W; Tan Q; Xie C; Sharma HS; Zhang Z
Int Rev Neurobiol; 2020; 151():281-297. PubMed ID: 32448612
[TBL] [Abstract][Full Text] [Related]
20. Pseudoprogression after glioma therapy: an update.
Galldiks N; Kocher M; Langen KJ
Expert Rev Neurother; 2017 Nov; 17(11):1109-1115. PubMed ID: 28862482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
